FDA Approvals - Anika Therapeutics Receives FDA Approvable Letter For Its Cosmetic Tissue
Anika Therapeutics Receives FDA Approvable Letter For Its Cosmetic Tissue Augmentation Product (Medical News Today)
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has received an FDA approvable letter for its cosmetic tissue augmentation ("CTA") product. CTA is an injectable soft tissue filler for facial wrinkles, scar remediation and lip augmentation. [click link for full article]
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP (Business Wire via Yahoo! Finance)
LOS ANGELES----Abraxis BioScience, Inc. , an integrated, global biopharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for the combination drug Ampicillin and Sulbactam for Injection, 15g, USP, the generic equivalent of Pfizer Inc.'s Unasyn .